You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

transplantation ex-vivo expanded limbal epithelium

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)

Recruiting
  • Hematologic Malignancy
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Mar 12, 2022

Hypospadias Trial in Milan ("Ex vivo" expanded autologous human oral epithelium containing stem cells)

Recruiting
  • Hypospadias
  • "Ex vivo" expanded autologous human oral epithelium containing stem cells
  • Milan, Italy
    Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico
Feb 21, 2022

Corneal Scars and Opacities Trial (Ex-vivo cultivated Allogeneic limbal stromal stem cells)

Not yet recruiting
  • Corneal Scars and Opacities
  • Ex-vivo cultivated Allogeneic limbal stromal stem cells
  • (no location specified)
Jun 12, 2021

Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • Haploidentical IL-21-Expanded Natural Killer Cells
  • Los Angeles, California
    Children's Hospital Los Angeles
Nov 1, 2021

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • EAGD T-cell infusion (Phase I)
  • EAGD T-cell infusion (Expansion)
  • Westwood, Kansas
    University of Kansas Cancer Center
Mar 15, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United

Completed
Has Results
  • Acute Biphenotypic Leukemia
  • +4 more
  • Duarte, California
  • +7 more
Jun 13, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham

Completed
Has Results
  • Acute Lymphoblastic Leukemia (ALL)
  • +4 more
  • Maywood, Illinois
  • +1 more
Aug 1, 2021

Viral Infections, Bone Marrow Transplant Infection Trial in Washington (Virus Specific T cells (VSTs))

Recruiting
  • Viral Infections
  • Bone Marrow Transplant Infection
  • Virus Specific T cells (VSTs)
  • Washington, District of Columbia
    Childrens National Medical Center
Oct 12, 2021

Acute Myeloid Leukemia Trial in Praha (OmnImmune®)

Completed
  • Acute Myeloid Leukemia
  • OmnImmune®
  • Praha, Czechia
    UHKT (Ustav hematologie a krevni transfuze)
Mar 29, 2021

Long Term Follow Up Protocol for NiCord®/CordIn™ Patients

Active, not recruiting
  • Patients Transplanted With NiCord/CordIn (Omidubicel)
  • NiCord®/CordIn™ (omidubicel)
  • Oakland, California
  • +9 more
Oct 31, 2022

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Limbal Stem-cell Deficiency Trial in Moscow (Labial mucosal epithelium grafting for corneal limbus substitution)

Enrolling by invitation
  • Limbal Stem-cell Deficiency
  • Labial mucosal epithelium grafting for corneal limbus substitution
  • Moscow, Russian Federation
    The S. Fyodorov Eye Microsurgery Federal State Institution
Aug 9, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)

Completed
Has Results
  • Hematological Malignancies
  • +3 more
  • Los Angeles, California
  • +14 more
Oct 1, 2020

Breast Hypoplasia and Facial Ageing Trial in Copenhagen (ASC enriched lipofilling, Standard Lipofilling)

Completed
  • Breast Hypoplasia and Facial Ageing
  • ASC enriched lipofilling
  • Standard Lipofilling
  • Copenhagen, Søborg, Denmark
    Stemform
Nov 24, 2022

Total Bilateral Limbal Cell Deficiency Trial in Lyon (FEMJA transplatation)

Recruiting
  • Total Bilateral Limbal Cell Deficiency
  • FEMJA transplatation
  • Lyon, France
    Ophthalmology department, Edouard Herriot hospital, Hospices Civ
Jan 26, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Lung Diseases Trial in Vienna (hemodiafiltration (HDF), Ex vivo lung perfusion (EVLP))

Recruiting
  • Lung Diseases
  • hemodiafiltration (HDF)
  • Ex vivo lung perfusion (EVLP)
  • Vienna, Austria
    Medical University of Vienna
Oct 9, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Beijing (Ex-vivo expanded ?d T cell infusion)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Ex-vivo expanded γδ T cell infusion
  • Beijing, China
    Chinese PLA General Hospital
Mar 24, 2022

Limbal Stem Cell Deficiency Trial in Boston (Biopsy to collect limbal epithelial stem cells that will be cultivated into a

Active, not recruiting
  • Limbal Stem Cell Deficiency
  • Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft
  • +2 more
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Mar 21, 2022

Keratoconus Trial (Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146%)

Not yet recruiting
  • Keratoconus
  • Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light
  • Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Jan 12, 2023

GVHD Trial in Tampa (Cultured Treg cells)

Completed
  • Graft Versus Host Disease
  • Cultured Treg cells
  • Tampa, Florida
    H Lee Moffitt Cancer Center
Nov 2, 2022

High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)

Recruiting
  • High-risk Leukemias
  • NK cells stimulated ex vivo with IL-15
  • Alloreactive NK cells
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Mar 30, 2022

Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

Recruiting
  • Acute Graft Versus Host Disease
  • MSCTC-0010 Dose Escalation
  • Kansas City, Kansas
    Kansas University Cancer Center
Jan 30, 2023

Cultivated Limbal Epithelial Transplantation for Limbal Stem

Not yet recruiting
  • Limbal Stem-cell Deficiency
    • Valladolid, Spain
      IOBA
    Feb 4, 2022